Free Consultation (800) 424-6690 Free Consultation (800) 424-6690 | [email protected]

Newsroom Search

featured news

September 7, 2015 Healthcare Fraud

Quest Diagnostics to Pay $1.79 Million to Settle Fraud Claims

Under the guidelines of Medicare Part B, enrollees are entitled to coverage for medically necessary and essential diagnostic services, including bloodwork, x-rays, and similar imaging examinations. If a provider fails to adhere to the Medicare guidelines, it could quickly face liability under the False Claims Act for unlawfully billing the […]
September 1, 2015 Reverse False Claims

District Court Offers Interpretation of “Identification” in Reverse False Claims Act Cases

As we have discussed in the past on this blog, the concept of “reverse false claims” has become more and more prevalent among False Claims Act cases. In general, a reverse false claim occurs when a government contractor, often a healthcare provider, receives overpayment for an otherwise legitimate invoice. Under […]
August 20, 2015 Healthcare Fraud

Tennessee Hospital Agrees to Settle Allegations of False Billing and Unlawful Practices

Of the various ways in which healthcare providers can violate the False Claims Act, ordering medically unnecessary procedures – particularly those involving the cardiac system – are considered particularly egregious. As opposed to illegal upcoding or kickback schemes, the performance of medically unnecessary procedures actually places patients directly in harm’s […]
July 20, 2015 Healthcare Fraud

Courts Considering Concept of Inflated ‘Risk Adjustment Scores’ Under the False Claims Act

According to a report published by the Center for Public Integrity, as many as six separate whistleblower lawsuits have been filed since 2010 alleging inflated ‘risk adjustment scores’ submitted to the Center for Medicare and Medicaid Services (CMS). This paradigm shift in alleging false claims centers on the notion that […]
June 30, 2015 Healthcare Fraud

Department of Justice Turns Eye Toward Settlement Over Off-Label Marketing of Conjunctivitis Drug

When reimbursing for prescription medication, agencies like Medicare and Medicaid are only permitted to pay claims for drugs that are prescribed for their approved use. When a doctor or pharmaceutical company prescribes or promotes a drug for an unapproved use, subsequent invoices for reimbursement could trigger False Claims Act liability.
schedule a free consultation

"*" indicates required fields

By clicking SUBMIT you agree to our Terms of Use and Privacy Policy and you are providing express consent to receive communications from Berger Montague via calls, emails, and/or text messages.

in Settlements & Verdicts
Years of High-Profile Cases
Attorneys Protecting Your Rights
Named “Trial Lawyer of the Year”
States in Which The Firm Has Successfully Litigated Cases

On the Cutting Edge of the Profession

Legal Intelligencer